JOHN H ABELES Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN H ABELES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN H ABELES. JOHN H ABELES is a in Medite Cancer Diagnostics, Inc. ($MDIT) and a Director in ORYX TECHNOLOGY CORP ($ORYX) and a Director in DUSA PHARMACEUTICALS INC ($DUSA) and a 10% Owner in Neurotrope, Inc. ($NTRP).
Address: 2365 NW 41ST STREET BOCA RATON 33431 FL
Companies in which JOHN H ABELES is an Insider
DUSA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN H ABELES: Director
Holdings: 77,000 shares
Latest Transaction: Jul 01 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Medite Cancer Diagnostics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHN H ABELES:
Holdings: 1,300,185 shares
Current Value: $585,083
Latest Transaction: Oct 23 2018
$MDIT Market Capitalization: $9.57M
$MDIT Previous Close: $0.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neurotrope, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN H ABELES: 10% Owner
Holdings: 0 shares
Latest Transaction: Nov 17 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ORYX TECHNOLOGY CORP
Industry: ELECTRICAL INDUSTRIAL APPARATUS [3620]
Position of JOHN H ABELES: Director
Holdings: 2,458 shares
Current Value: $49
Latest Transaction: Dec 08 2005
$ORYX Market Capitalization: $113525.00
$ORYX Previous Close: $0.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN H ABELES
Sentiment: All, DUSA, MDIT, NTRP, ORYX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23 2018 | MDIT | Medite Cancer Diag ... | ABELES JOHN H | Buy | P | 0.08 | 266,667 | 20,000 | 1,566,852 | 1.3 M to 1.6 M (+20.51 %) | |
| Oct 23 2018 | MDIT | Medite Cancer Diag ... | ABELES JOHN H | Buy | J | 0.00 | 40,000 | 0 | 1,300,185 | 1.3 M to 1.3 M (+3.17 %) | |
| Jul 10 2018 | MDIT | Medite Cancer Diag ... | ABELES JOHN H | Buy | P | 0.08 | 400,000 | 30,000 | 2,608,381 | 2.2 M to 2.6 M (+18.11 %) | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | A | 1.50 | 166,667 | 250,001 | 166,667 | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | A | 1.00 | 166,667 | 166,667 | 166,667 | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | A | 1.25 | 166,667 | 208,334 | 166,667 | |
| Nov 17 2015 | NTRP | Neurotrope, Inc. | ABELES JOHN H | 10% Owner | Option Exercise | A | 0.80 | 166,667 | 133,334 | 166,667 |